| Dr.
Sullivan's lab
This Page is currently under
construction . . .
Research Hightlight -
Dr. Sullivan is currently developing novel therapies for
retinal and macular degeneration, based on mutations in genes
in human photoreceptor cells and retinal pigment epithelium.
He is also studying the mechanisms of pathological angiogenesis
in proliferative ischemic retinopathies and maculopathies
Armed with this information on mechanisms, he is working to
develop gene-based therapeutics, such as ribozymes and siRNA.
Resources and suppliers
Please contact Dr. Sullivan for more information at js354@buffalo.edu
People
John Sullivan, MD, PhD
Facilities
Email: js354@buffalo.edu
|
